Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages

Author:

Yuan Wei12ORCID,Zhang Qian3ORCID,Gu Danling3ORCID,Lu Chenfei34ORCID,Dixit Deobrat5ORCID,Gimple Ryan C.6ORCID,Gao Yisu7ORCID,Gao Jiancheng34ORCID,Li Daqi3ORCID,Shan Danyang3ORCID,Hu Lang34ORCID,Li Lu3ORCID,Li Yangqing8ORCID,Ci Shusheng3ORCID,You Hao3ORCID,Yan Linping3ORCID,Chen Kexin3ORCID,Zhao Ningwei9ORCID,Xu Chuanhai1ORCID,Lan Jianyun1ORCID,Liu Dong10ORCID,Zhang Junxia4ORCID,Shi Zhumei4ORCID,Wu Qiulian511ORCID,Yang Kailin12ORCID,Zhao Linjie5ORCID,Qiu Zhixin13ORCID,Lv Deguan5ORCID,Gao Wei3ORCID,Yang Hui14ORCID,Lin Fan3ORCID,Wang Qianghu15ORCID,Man Jianghong16ORCID,Li Chaojun8ORCID,Tao Weiwei17ORCID,Agnihotri Sameer18ORCID,Qian Xu1519ORCID,Mack Stephen C.20ORCID,Zhang Nu21ORCID,You Yongping4ORCID,Rich Jeremy N.51122ORCID,Sun Guan27ORCID,Wang Xiuxing31523ORCID

Affiliation:

1. 1Department of Pathology, The Yancheng Clinical College of Xuzhou Medical University, The First people's Hospital of Yancheng, Yancheng, Jiangsu, China.

2. 2Department of Central Laboratory, Yancheng Medical Research Center of Nanjing University Medical School, Yancheng, Jiangsu, China.

3. 3National Health Commission Key Laboratory of Antibody Techniques, Department of Cell Biology, Jiangsu Provincial Key Laboratory of Human Functional Genomics, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.

4. 4Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

5. 5Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, California.

6. 6Department of Pathology, Case Western Reserve University, Cleveland, Ohio.

7. 7Department of Neurosurgery, The Yancheng Clinical College of Xuzhou Medical University, The First people's Hospital of Yancheng, Yancheng, Jiangsu, China.

8. 8Ministry of Education Key Laboratory of Model Animals for Disease Study, Model Animal Research Center and School of Medicine, Nanjing University, National Resource Center for Mutant Mice, Nanjing, Jiangsu, China.

9. 9China Exposomics Institute, Shanghai, China.

10. 10School of Life Science, Nantong Laboratory of Development and Diseases, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, China.

11. 11UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.

12. 12Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.

13. 13Institute for Translational Brain Research, Fudan University, Shanghai, China.

14. 14Department of Neurosurgery, Huashan Hospital, Shanghai Key laboratory of Brain Function Restoration and Neural Regeneration, Shanghai Clinical Medical Center of Neurosurgery, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institute for Translational Brain Research, Shanghai Medical College, Fudan University, Shanghai, China.

15. 15Institute for Brain Tumors, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.

16. 16State Key Laboratory of Proteomics, National Center of Biomedical analysis, Beijing, China.

17. 17College of Biomedicine and Health & College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.

18. 18Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

19. 19Department of Nutrition and Food Hygiene, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.

20. 20Division of Brain Tumor Research, Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee.

21. 21Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Brain Function and Disease, Guangdong Translational Medicine Innovation Platform, Guangzhou, Guangdong, China.

22. 22Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania.

23. 23Jiangsu Cancer Hospital, Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Abstract

Abstract Purpose: The dynamic interplay between glioblastoma stem cells (GSC) and tumor-associated macrophages (TAM) sculpts the tumor immune microenvironment (TIME) and promotes malignant progression of glioblastoma (GBM). However, the mechanisms underlying this interaction are still incompletely understood. Here, we investigate the role of CXCL8 in the maintenance of the mesenchymal state of GSC populations and reprogramming the TIME to an immunosuppressive state. Experimental Design: We performed an integrative multi-omics analyses of RNA sequencing, GBM mRNA expression datasets, immune signatures, and epigenetic profiling to define the specific genes expressed in the mesenchymal GSC subsets. We then used patient-derived GSCs and a xenograft murine model to investigate the mechanisms of tumor-intrinsic and extrinsic factor to maintain the mesenchymal state of GSCs and induce TAM polarization. Results: We identified that CXCL8 was preferentially expressed and secreted by mesenchymal GSCs and activated PI3K/AKT and NF-κB signaling to maintain GSC proliferation, survival, and self-renewal through a cell-intrinsic mechanism. CXCL8 induced signaling through a CXCR2–JAK2/STAT3 axis in TAMs, which supported an M2-like TAM phenotype through a paracrine, cell-extrinsic pathway. Genetic- and small molecule–based inhibition of these dual complementary signaling cascades in GSCs and TAMs suppressed GBM tumor growth and prolonged survival of orthotopic xenograft-bearing mice. Conclusions: CXCL8 plays critical roles in maintaining the mesenchymal state of GSCs and M2-like TAM polarization in GBM, highlighting an interplay between cell-autonomous and cell-extrinsic mechanisms. Targeting CXCL8 and its downstream effectors may effectively improve GBM treatment.

Funder

National Natural Science Foundation of China

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3